Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Madhav Bhatt

Madhav Bhatt

ID: 1b83b09b-2619-30fb-68c4

/

Claimed Record

/

Organization: Reed Smith LLP

FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B

Health Industry Washington Watch · April 2, 2024

OIG approves arrangement involving free drug samples for inpatient hospital use

Health Industry Washington Watch · January 24, 2023

OIG approves arrangement involving a testamentary gift to a nonprofit hospital to reduce costs for pediatric patients

Health Industry Washington Watch · February 23, 2022

Practice Areas

Health Care and Life Sciences

Jurisdictions

Publishing Record

Publisher Since 2022

Total Articles 3

Most Recent April 2, 2024

Cite This Author

Madhav Bhatt, Reed Smith LLP

LexBlog Author ID:

1b83b09b-2619-30fb-68c4

www.lexblog.com/author/mbhatt

Contact

FirmReed Smith LLP

Emailmbhatt@reedsmith.com

BlogHealth Industry Washington Watch

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog